There are piles of close to zero cost options and early issued shares that are tradeable - management primarily, I think. I presume that is what is occurring.
But as far as the company goes, I don’t see why it can’t say how the trials are going structurally - ie, has Covid disrupted things, is it going to delay results, is there anything else going on etc? Something. Anything. It’s just crickets otherwise.
EBR news, page-26
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.000(0.00%) |
Mkt cap ! $314.2M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.05 | 99.0¢ | $143.8K | 142.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1565 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 35157 | 1 |
View Market Depth
| Last trade - 15.48pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
99.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| $1.00 | $1.03 | 99.0¢ | 18158 | ||
| Last updated 15.48pm 15/05/2024 ? | |||||
| EBR (ASX) Chart |